Article
BRCAness revisited.
Nature reviews. Cancer - 1 Feb 2016
Lord Christopher J, Ashworth Alan
Abstract excerpt
Over the past 20 years, there has been considerable progress in our understanding of the biological functions of the BRCA1 and BRCA2 cancer susceptibility genes. This has led to the development of new therapeutic approaches that target tumours with loss-of-function mutations in either BRCA1 or BRCA2. Tumours that share molecular features of BRCA-mutant tumours - that is, those with 'BRCAness' - may also respond...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
